Grace Therapeutics (L8S.F) Q4 2024 Earnings

13NovConfirmed
Q3 2024
Q4 2024
-0.35
-0.31
-0.26
-0.22

Details

Expected EPS
-0.35026419999999997
Actual EPS
-0.283998
Surprise EPS
0.07
Surprise Percent
+18.92%

Description

Grace Therapeutics (L8S.F) has reported earnings of -0.283998 per share for Q4 2024.

0 Comments

Share your thoughts